XBiotech Inc. (XBIT) — Financial statements
Income statement, balance sheet, and cash flow for XBiotech Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00↓100.0% | 4↓78.2% | 18 | |
| Cost of Revenue | 2 | 0.00 | 0.00↓100.0% | 0.65↓88.8% | 6 | |
| Gross Profit | -2 | 0.00 | 0.00↓100.0% | 3↓73.3% | 13 | |
| Operating Expenses | ||||||
| R&D Expenses | 47↑25.5% | 38↑14.9% | 33↑4.1% | 32↑11.6% | 28 | |
| General & Administrative Expenses | 8↑76.0% | 5↑1.1% | 5↓26.1% | 6↓32.8% | 9 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 8↑76.0% | 5↑1.1% | 5↓26.1% | 6↓32.8% | 9 | |
| Other Expenses | -2 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 54↑27.1% | 42↑13.2% | 38↓0.9% | 38↑0.5% | 38 | |
| Total Costs & Expenses | 56↑31.1% | 42↑13.2% | 38↓2.6% | 39↓11.4% | 43 | |
| Operating Results | ||||||
| Operating Income | -56↓31.1% | -42↓13.2% | -38↓8.8% | -34↓37.5% | -25 | |
| Depreciation & Amortization | 2↓3.4% | 2↑0.1% | 2↓33.3% | 3↓1.3% | 3 | |
| EBITDA | -54↓50.0% | -36↓59.6% | -23↑29.2% | -32↓42.1% | -22 | |
| EBIT | -56↓47.5% | -38↓55.3% | -24↑29.5% | -34↓37.5% | -25 | |
| Interest & Other Income | ||||||
| Net Interest Income | 6↓37.9% | 9↓13.6% | 10↑172.6% | 4↑718.6% | 0.47 | |
| Interest Income | 6↓42.1% | 10↓5.8% | 10↑172.6% | 4↑718.6% | 0.47 | |
| Interest Expense | 0.09↓89.1% | 0.81 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -5↑64.3% | -13 | 0.00 | 0.00 | |
| Other Income / Expenses | 10↑165.6% | 4↓70.4% | 13↑1363.1% | 0.90↑339.9% | -0.38 | |
| Income Before Tax | -45↓17.5% | -39↓58.6% | -24↑27.6% | -34↓31.9% | -25 | |
| Income Tax Expense | 0.24↑834.4% | -0.03↓113.1% | 0.24↑135.5% | -0.69↑91.4% | -8 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -46↓18.2% | -39↓56.9% | -25↑25.4% | -33↓88.9% | -17 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -46↓18.2% | -39↓56.9% | -25↑25.4% | -33↓88.9% | -17 | |
| Bottom-Line Net Income | -46↓18.2% | -39↓56.9% | -25↑25.4% | -33↓88.9% | -17 | |
| EPS (Basic) | -1.49↓18.3% | -1.26↓55.6% | -0.81↑25.0% | -1.08↓86.2% | -0.58 | |
| EPS (Diluted) | -1.49↓18.3% | -1.26↓55.6% | -0.81↑25.0% | -1.08↓86.2% | -0.58 | |
| Weighted Average Shares | 30↑0.1% | 30↑0.5% | 30↓0.4% | 30↑1.3% | 30 | |
| Weighted Average Diluted Shares | 30↑0.1% | 30↑0.1% | 30↓0.0% | 30↑1.3% | 30 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.